Author

Francisco Rodriguez-Moranta

PROTON PUMP INHIBITORS AND FAECAL IMMUNOCHEMICAL TEST FOR THE DETECTION OF ADVANCED NEOPLASIA IN SYMPTOMATIC POPULATION
PROTON PUMP INHIBITORS AND FAECAL IMMUNOCHEMICAL TEST FOR THE DETECTION OF ADVANCED NEOPLASIA IN SYMPTOMATIC POPULATION

Francisco Rodriguez-Moranta  et al.

EXTERNAL VALIDATION OF A FAECAL IMMUNOCHEMICAL TEST BASED-RISK SCORE FOR ADVANCED NEOPLASIA IN A BRITISH SYMPTOMATIC POPULATION
EXTERNAL VALIDATION OF A FAECAL IMMUNOCHEMICAL TEST BASED-RISK SCORE FOR ADVANCED NEOPLASIA IN A BRITISH SYMPTOMATIC POPULATION

Francisco Rodriguez-Moranta  et al.

EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY
EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Francisco Rodriguez-Moranta  et al.

LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY
LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Francisco Rodriguez-Moranta  et al.

PREVALENCE OF ADENOMAS IN LYNCH SYNDROME: GENE-SPECIFIC ANALYSIS AND COMPARISON WITH AVERAGE AND FAMILIAL CRC RISK POPULATIONS
PREVALENCE OF ADENOMAS IN LYNCH SYNDROME: GENE-SPECIFIC ANALYSIS AND COMPARISON WITH AVERAGE AND FAMILIAL CRC RISK POPULATIONS

Francisco Rodriguez-Moranta  et al.

ASSOCIATION BETWEEN COLONOSCOPY QUALITY INDICATORS, DIAGNOSTIC YIELD, AND POST COLONOSCOPY COLORECTAL CANCER INCIDENCE IN LYNCH SYNDROME
ASSOCIATION BETWEEN COLONOSCOPY QUALITY INDICATORS, DIAGNOSTIC YIELD, AND POST COLONOSCOPY COLORECTAL CANCER INCIDENCE IN LYNCH SYNDROME

Francisco Rodriguez-Moranta  et al.

Item 1 - 6 / 6
1